A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the 340B Drug Pricing Program by preventing any limitations on the number of pharmacies ...

A federal judge in Maine has temporarily blocked the Department of Health and Human Services from implementing a pilot for a 340B rebate model. On Dec. 29, Judge Lance Walker ruled in favor of the ...

A significant development unfolded on December 29, 2025, as the U.S. District Court for the District of Maine issued a preliminary injunction blocking the U.S. Department of Health and Human Services ...

PORTLAND, Maine (WMTW) - The U.S. Department of Health and Human Services is appealing after a federal judge in Maine this week ruled that the federal government cannot start making changes to a drug ...

A federal judge on Monday temporarily blocked the U.S. administration’s planned 340B Rebate Model Pilot Program, finding that regulators likely failed to meet basic administrative law requirements ...

A federal judge in Maine has put the brakes on a pilot program that would have enabled biopharma companies to offer rebates instead of discounts as part of the 340B program beginning Jan. 1, 2026.

Let’s talk about 340B, the drug pricing problem that you may not have heard of, but the one that seems to have swallowed the federal budget. The program started as an attempt to help hospitals that ...

As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it. The 340B Drug Pricing ...